Matthew McManus - Feb 1, 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
President - DGS
Signature
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/5/2024, 06:35 PM
Previous filing
Feb 5, 2024
Next filing
Aug 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Award $0 +2.89K $0.00 2.89K Feb 1, 2024 Common Stock 2.89K Direct F1, F2
transaction TECH Restricted Stock Units Award $0 +13.9K $0.00 13.9K Feb 1, 2024 Common Stock 13.9K Direct F1, F3
transaction TECH Stock Option (Right to Buy) Award $0 +7.95K $0.00 7.95K Feb 1, 2024 Common Stock 7.95K $68.54 Direct F2
transaction TECH Stock Option (Right to Buy) Award $0 +15.9K $0.00 15.9K Feb 1, 2024 Common Stock 15.9K $68.54 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
F4 Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.